Guggenheim maintained a Buy rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $35.00 (from $65.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

RBC Capital Downgrades Endo International plc (ENDP) to Sector PerformMay 6, 2016 6:47 AM Piper Jaffray Downgrades Endo International plc (ENDP) to NeutralMay 6, 2016 6:29 AM Mizuho Securities Downgrades Endo International plc (ENDP) to Underperform; Stock is 'Toxic'May 6, 2016 6:26 AM Leerink Partners Downgrades Endo International plc (ENDP) to Market PerformMay 6, 2016 6:24 AM After-Hours Stock Movers 05/05: (HLF) (RATE) (YELP) Higher; (GST) (ENDP) (IMPV) Lower (more...)May 5, 2016 6:24 PM Endo Int'l (ENDP) Names Douglas S. Ingram and Todd B. Sisitsky to BoardMay 5, 2016 4:23 PM Endo Int'l (ENDP) Tops Q1 EPS by 4c, Guides FY Well Below ConsensusMay 5, 2016 4:22 PM Endo Int'l (ENDP) Says Brian Lortie President U.S. Branded Pharmaceuticals to Step DownMay 5, 2016 4:20 PM Endo Announces Change to Senior Management TeamMay 5, 2016 4:11 PM Endo Announces Appointment of Douglas S. Ingram and Todd B. Sisitsky to its Board of DirectorsMay 5, 2016 4:06 PM Endo Reports First Quarter 2016 Financial ResultsMay 5, 2016 4:06 PM Trading Radar for 5/5: Alibaba (BABA), GoPro (GPRO), Herbalife (HLF), Wynn Resorts (WYNN), Activision (ATVI) ReportMay 4, 2016 2:39 PM